Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 638

1.

Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer.

Yoshino Y, Taguchi A, Takao M, Kashiyama T, Furusawa A, Uno M, Okada S, Kino N, Yasugi T.

Int J Clin Oncol. 2018 Nov 30. doi: 10.1007/s10147-018-1374-4. [Epub ahead of print]

PMID:
30506281
2.

The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway.

Ogishima J, Taguchi A, Kawata A, Kawana K, Yoshida M, Yoshimatsu Y, Sato M, Nakamura H, Kawata Y, Nishijima A, Fujimoto A, Tomio K, Adachi K, Nagamatsu T, Oda K, Kiyono T, Osuga Y, Fujii T.

BMC Cancer. 2018 Dec 3;18(1):1201. doi: 10.1186/s12885-018-4922-4.

3.

Improvement of region of interest extraction and scanning method of computer-aided diagnosis system for osteoporosis using panoramic radiographs.

Nakamoto T, Taguchi A, Verdonschot RG, Kakimoto N.

Oral Radiol. 2018 Apr 25. doi: 10.1007/s11282-018-0330-3. [Epub ahead of print]

PMID:
30484188
4.

Long waiting time before tooth extraction may increase delayed wound healing in elderly Japanese.

Kamimura M, Taguchi A, Komatsu M, Koiwai H, Ashizawa R, Ichinose A, Takahara K, Uchiyama S, Kato H.

Osteoporos Int. 2018 Nov 20. doi: 10.1007/s00198-018-4775-3. [Epub ahead of print]

PMID:
30460382
5.

Expression of Nerve Injury-Induced Protein1 (Ninj1) in Endometriosis.

Miyashita M, Koga K, Takeuchi A, Makabe T, Taguchi A, Urata Y, Izumi G, Takamura M, Harada M, Hirata T, Hirota Y, Wada-Hiraike O, Yoshino O, Fujii T, Osuga Y.

Reprod Sci. 2018 Oct 16:1933719118806395. doi: 10.1177/1933719118806395. [Epub ahead of print]

PMID:
30326781
6.

Regenerative potential of induced pluripotent stem cells derived from patients undergoing haemodialysis in kidney regeneration.

Tajiri S, Yamanaka S, Fujimoto T, Matsumoto K, Taguchi A, Nishinakamura R, Okano HJ, Yokoo T.

Sci Rep. 2018 Oct 8;8(1):14919. doi: 10.1038/s41598-018-33256-7.

7.

[A Case of Carotid Artery Stenosis Associated with Repetitive Stimulation of the Hyoid Bone].

Taguchi A, Ohba S, Itoh Y, Ohshita J, Yonezawa K.

No Shinkei Geka. 2018 Sep;46(9):811-818. doi: 10.11477/mf.1436203818. Japanese.

PMID:
30262686
8.

Metal-free class Ie ribonucleotide reductase from pathogens initiates catalysis with a tyrosine-derived dihydroxyphenylalanine radical.

Blaesi EJ, Palowitch GM, Hu K, Kim AJ, Rose HR, Alapati R, Lougee MG, Kim HJ, Taguchi AT, Tan KO, Laremore TN, Griffin RG, Krebs C, Matthews ML, Silakov A, Bollinger JM Jr, Allen BD, Boal AK.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):10022-10027. doi: 10.1073/pnas.1811993115. Epub 2018 Sep 17.

9.

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2018 Sep 12. doi: 10.1038/s41436-018-0258-3. [Epub ahead of print]

PMID:
30209272
10.

Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2018 Sep 7. doi: 10.1038/s41436-018-0125-2. [Epub ahead of print]

PMID:
30190610
11.

Organoids from Nephrotic Disease-Derived iPSCs Identify Impaired NEPHRIN Localization and Slit Diaphragm Formation in Kidney Podocytes.

Tanigawa S, Islam M, Sharmin S, Naganuma H, Yoshimura Y, Haque F, Era T, Nakazato H, Nakanishi K, Sakuma T, Yamamoto T, Kurihara H, Taguchi A, Nishinakamura R.

Stem Cell Reports. 2018 Sep 11;11(3):727-740. doi: 10.1016/j.stemcr.2018.08.003. Epub 2018 Aug 30.

12.

A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer.

Fahrmann JF, Bantis LE, Capello M, Scelo G, Dennison JB, Patel N, Murage E, Vykoukal J, Kundnani DL, Foretova L, Fabianova E, Holcatova I, Janout V, Feng Z, Yip-Schneider M, Zhang J, Brand R, Taguchi A, Maitra A, Brennan P, Max Schmidt C, Hanash S.

J Natl Cancer Inst. 2018 Aug 18. doi: 10.1093/jnci/djy126. [Epub ahead of print]

PMID:
30137376
13.

Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.

Yoshida M, Taguchi A, Kawana K, Ogishima J, Adachi K, Kawata A, Nakamura H, Sato M, Fujimoto A, Inoue T, Tomio K, Mori M, Nagamatsu T, Arimoto T, Koga K, Hiraike OW, Oda K, Kiyono T, Osuga Y, Fujii T.

Int J Oncol. 2018 Oct;53(4):1580-1590. doi: 10.3892/ijo.2018.4504. Epub 2018 Jul 26.

14.

Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04.

Uemura Y, Tanaka S, Miyazaki T, Tsukiyama M, Sone T, Taguchi A, Soen S, Mori S, Hagino H, Sugimoto T, Fukunaga M, Ohta H, Nakamura T, Orimo H, Shiraki M; Adequate Treatment of Osteoporosis (A-TOP) research group.

J Bone Miner Metab. 2018 Jul 17. doi: 10.1007/s00774-018-0942-z. [Epub ahead of print]

PMID:
30019249
15.

Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.

Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Consortium for Early Detection of Lung Cancer, Guida F, Sun N, Bantis LE, Muller DC, Li P, Taguchi A, Dhillon D, Kundnani DL, Patel NJ, Yan Q, Byrnes G, Moons KGM, Tjønneland A, Panico S, Agnoli C, Vineis P, Palli D, Bueno-de-Mesquita B, Peeters PH, Agudo A, Huerta JM, Dorronsoro M, Barranco MR, Ardanaz E, Travis RC, Byrne KS, Boeing H, Steffen A, Kaaks R, Hüsing A, Trichopoulou A, Lagiou P, La Vecchia C, Severi G, Boutron-Ruault MC, Sandanger TM, Weiderpass E, Nøst TH, Tsilidis K, Riboli E, Grankvist K, Johansson M, Goodman GE, Feng Z, Brennan P, Johansson M, Hanash SM.

JAMA Oncol. 2018 Oct 1;4(10):e182078. doi: 10.1001/jamaoncol.2018.2078. Epub 2018 Oct 11.

PMID:
30003238
16.

Metformin treatment ameliorates diabetes-associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1.

Tanokashira D, Kurata E, Fukuokaya W, Kawabe K, Kashiwada M, Takeuchi H, Nakazato M, Taguchi A.

FEBS Open Bio. 2018 May 18;8(7):1104-1118. doi: 10.1002/2211-5463.12436. eCollection 2018 Jul. Erratum in: FEBS Open Bio. 2018 Oct 22;8(11):1882-1883.

17.

g-Tensor Directions in the Protein Structural Frame of Hyperthermophilic Archaeal Reduced Rieske-Type Ferredoxin Explored by 13C Pulsed Electron Paramagnetic Resonance.

Taguchi AT, Ohmori D, Dikanov SA, Iwasaki T.

Biochemistry. 2018 Jul 17;57(28):4074-4082. doi: 10.1021/acs.biochem.8b00438. Epub 2018 Jun 21.

PMID:
29890072
18.

Two-Dimensional Pulsed EPR Resolves Hyperfine Coupling Strain in Nitrogen Hydrogen Bond Donors of Semiquinone Intermediates.

Dikanov SA, Taguchi AT.

J Phys Chem B. 2018 May 24;122(20):5205-5211. doi: 10.1021/acs.jpcb.8b02511. Epub 2018 May 10.

PMID:
29697981
19.

Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer.

Sato M, Taguchi A, Fukui Y, Kawata A, Taguchi S, Kashiyama T, Eguchi S, Inoue T, Tomio K, Tanikawa M, Sone K, Mori M, Nagasaka K, Adachi K, Ikemura M, Domoto Y, Arimoto T, Oda K, Fukayama M, Osuga Y, Fujii T.

Int J Gynecol Cancer. 2018 Jun;28(5):875-881. doi: 10.1097/IGC.0000000000001262.

PMID:
29664845
20.

Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy.

Kamimura M, Taguchi A, Nakamura Y, Koiwai H, Ikegami S, Uchiyama S, Kato H.

Ther Clin Risk Manag. 2018 Apr 3;14:637-642. doi: 10.2147/TCRM.S154686. eCollection 2018.

21.

Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products.

Houkin K, Shichinohe H, Abe K, Arato T, Dezawa M, Honmou O, Horie N, Katayama Y, Kudo K, Kuroda S, Matsuyama T, Miyai I, Nagata I, Niizuma K, Sakushima K, Sasaki M, Sato N, Sawanobori K, Suda S, Taguchi A, Tominaga T, Yamamoto H, Yamashita T, Yoshimine T; Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction.

Stroke. 2018 Apr;49(4):e145-e152. doi: 10.1161/STROKEAHA.117.019216. Epub 2018 Mar 16. Review. No abstract available.

PMID:
29581346
22.

Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL.

Nakamura H, Taguchi A, Kawana K, Baba S, Kawata A, Yoshida M, Fujimoto A, Ogishima J, Sato M, Inoue T, Nishida H, Furuya H, Yamashita A, Eguchi S, Tomio K, Mori-Uchino M, Adachi K, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T.

Oncotarget. 2018 Feb 5;9(17):13451-13461. doi: 10.18632/oncotarget.24413. eCollection 2018 Mar 2.

23.

Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment.

Nakamura Y, Kamimura M, Morikawa A, Taguchi A, Suzuki T, Kato H.

Ther Clin Risk Manag. 2018 Mar 14;14:543-549. doi: 10.2147/TCRM.S156466. eCollection 2018.

24.

Medullary thick ascending limb impairment in the GlatmTg(CAG-A4GALT) Fabry model mice.

Maruyama H, Taguchi A, Nishikawa Y, Guili C, Mikame M, Nameta M, Yamaguchi Y, Ueno M, Imai N, Ito Y, Nakagawa T, Narita I, Ishii S.

FASEB J. 2018 Aug;32(8):4544-4559. doi: 10.1096/fj.201701374R. Epub 2018 Mar 19.

25.

Molecular clock as a regulator of β-cell function.

Taguchi A, Ohta Y, Tanizawa Y.

J Diabetes Investig. 2018 Mar 15. doi: 10.1111/jdi.12835. [Epub ahead of print]

26.

Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.

Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, Tamita K, Kawasaki T, Kajihara J, Onishi A, Sugiyama H, Sakai T, Murata I, Oda T, Toyoda S, Hanawa K, Fujimura T, Ura S, Matsumura M, Takano H, Yamashita S, Matsukura G, Tazawa R, Shiga T, Ebato M, Satoh H, Ishii S.

Genet Med. 2018 Mar 15. doi: 10.1038/gim.2018.31. [Epub ahead of print] Erratum in: Genet Med. 2018 Sep 7;:. Genet Med. 2018 Sep 12;:.

PMID:
29543226
27.

Issues with the surgical treatment of antiresorptive agent-related osteonecrosis of the jaws.

Kagami H, Inoue M, Kobayashi A, Taguchi A, Li X, Yoshizawa M.

Oral Dis. 2018 Mar;24(1-2):52-56. doi: 10.1111/odi.12783. Review.

PMID:
29480637
28.

4-Fluorophenyl 3-nitro-2-pyridinesulfenate as a practical protecting agent for amino acids.

Cui Y, Rentier C, Taguchi A, Takayama K, Taniguchi A, Hayashi Y.

J Pept Sci. 2018 Mar;24(3). doi: 10.1002/psc.3070. Epub 2018 Feb 15.

PMID:
29446187
29.

Development of a carboplatin derivative conjugated with a collagen-like triple-helical peptide.

Masuda R, Hayashi R, Nose H, Taguchi A, Hayashi Y, Yasui H, Koide T.

Future Med Chem. 2018 Mar 1;10(6):619-629. doi: 10.4155/fmc-2017-0183. Epub 2018 Feb 7.

PMID:
29412009
30.

Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer.

Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Ogishima J, Eguchi S, Yamashita A, Tomio K, Komatsu A, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T.

Oncol Lett. 2018 Jan;15(1):1357-1361. doi: 10.3892/ol.2017.7388. Epub 2017 Nov 9.

31.

Simultaneous Multiselective Spectroelectrochemical Fiber-Optic Sensor: Sensing with an Optically Transparent Electrode.

Okazaki T, Shiokawa E, Orii T, Yamamoto T, Hata N, Taguchi A, Sugawara K, Kuramitz H.

Anal Chem. 2018 Feb 20;90(4):2440-2445. doi: 10.1021/acs.analchem.7b03957. Epub 2018 Feb 8.

PMID:
29364653
32.

Involvement of immune cells in the pathogenesis of endometriosis.

Izumi G, Koga K, Takamura M, Makabe T, Satake E, Takeuchi A, Taguchi A, Urata Y, Fujii T, Osuga Y.

J Obstet Gynaecol Res. 2018 Feb;44(2):191-198. doi: 10.1111/jog.13559. Epub 2018 Jan 5. Review.

PMID:
29316073
33.

Unpaired Electron Spin Density Distribution across Reduced [2Fe-2S] Cluster Ligands by 13Cβ-Cysteine Labeling.

Taguchi AT, Miyajima-Nakano Y, Fukazawa R, Lin MT, Baldansuren A, Gennis RB, Hasegawa K, Kumasaka T, Dikanov SA, Iwasaki T.

Inorg Chem. 2018 Jan 16;57(2):741-746. doi: 10.1021/acs.inorgchem.7b02676. Epub 2017 Dec 26.

PMID:
29278328
34.

An Efficient Method for the Conjugation of Hydrophilic and Hydrophobic Components by Solid-Phase-Assisted Disulfide Ligation.

Muguruma K, Shirasaka T, Akiyama D, Fukumoto K, Taguchi A, Takayama K, Taniguchi A, Hayashi Y.

Angew Chem Int Ed Engl. 2018 Feb 19;57(8):2170-2173. doi: 10.1002/anie.201712324. Epub 2018 Jan 19.

PMID:
29276821
35.

HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.

Shiels MS, Kirk GD, Drummond MB, Dhillon D, Hanash SM, Taguchi A, Engels EA.

J Infect Dis. 2018 Jan 17;217(3):413-417. doi: 10.1093/infdis/jix510.

PMID:
29272472
36.

Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma.

Vykoukal J, Sun N, Aguilar-Bonavides C, Katayama H, Tanaka I, Fahrmann JF, Capello M, Fujimoto J, Aguilar M, Wistuba II, Taguchi A, Ostrin EJ, Hanash SM.

Oncotarget. 2017 Sep 8;8(56):95466-95480. doi: 10.18632/oncotarget.20748. eCollection 2017 Nov 10.

37.

Identification of a Functionally Unique Family of Penicillin-Binding Proteins.

Welsh MA, Taguchi A, Schaefer K, Van Tyne D, Lebreton F, Gilmore MS, Kahne D, Walker S.

J Am Chem Soc. 2017 Dec 13;139(49):17727-17730. doi: 10.1021/jacs.7b10170. Epub 2017 Nov 30.

PMID:
29182854
38.

Polycystic Ovarian Morphology may be a Positive Prognostic Factor in Patients with Endometrial Cancer who Achieved Complete Remission after Fertility-Sparing Therapy with Progestin

Fukui Y, Taguchi A, Adachi K, Sato M, Kawata A, Tanikawa M, Sone K, Mori M, Nagasaka K, Matsumoto Y, Arimoto T, Oda K, Osuga Y, Fujii T.

Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3111-3116.

39.

Au-Protected Ag Core/Satellite Nanoassemblies for Excellent Extra-/Intracellular Surface-Enhanced Raman Scattering Activity.

Zhang Z, Bando K, Taguchi A, Mochizuki K, Sato K, Yasuda H, Fujita K, Kawata S.

ACS Appl Mater Interfaces. 2017 Dec 20;9(50):44027-44037. doi: 10.1021/acsami.7b14976. Epub 2017 Dec 5.

PMID:
29171749
40.

Treatment evaluation of acute stroke for using in regenerative cell elements (TREASURE) trial: Rationale and design.

Osanai T, Houkin K, Uchiyama S, Minematsu K, Taguchi A, Terasaka S.

Int J Stroke. 2018 Jun;13(4):444-448. doi: 10.1177/1747493017743057. Epub 2017 Nov 14.

PMID:
29134924
41.

Higher-Order Kidney Organogenesis from Pluripotent Stem Cells.

Taguchi A, Nishinakamura R.

Cell Stem Cell. 2017 Dec 7;21(6):730-746.e6. doi: 10.1016/j.stem.2017.10.011. Epub 2017 Nov 9.

PMID:
29129523
42.

Structure-Activity Relationship Study of Leucyl-3-epi-deoxynegamycin for Potent Premature Termination Codon Readthrough.

Taguchi A, Hamada K, Shiozuka M, Kobayashi M, Murakami S, Takayama K, Taniguchi A, Usui T, Matsuda R, Hayashi Y.

ACS Med Chem Lett. 2017 Sep 29;8(10):1060-1065. doi: 10.1021/acsmedchemlett.7b00269. eCollection 2017 Oct 12.

43.

Conformationally Dynamic Radical Transfer within Ribonucleotide Reductase.

Greene BL, Taguchi AT, Stubbe J, Nocera DG.

J Am Chem Soc. 2017 Nov 22;139(46):16657-16665. doi: 10.1021/jacs.7b08192. Epub 2017 Nov 9.

44.

Determination of the Complete Spin Density Distribution in 13C-Labeled Protein-Bound Radical Intermediates Using Advanced 2D Electron Paramagnetic Resonance Spectroscopy and Density Functional Theory.

Taguchi AT, O'Malley PJ, Wraight CA, Dikanov SA.

J Phys Chem B. 2017 Nov 9;121(44):10256-10268. doi: 10.1021/acs.jpcb.7b10036. Epub 2017 Oct 31.

PMID:
29035062
45.

Chemotherapeutics overcoming nonsense mutation-associated genetic diseases: medicinal chemistry of negamycin.

Taguchi A, Hamada K, Hayashi Y.

J Antibiot (Tokyo). 2018 Feb;71(2):205-214. doi: 10.1038/ja.2017.112. Epub 2017 Sep 27. Review.

PMID:
28951602
46.

Correction for Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability.

Takayama K, Mori K, Tanaka A, Nomura E, Sohma Y, Mori M, Taguchi A, Taniguchi A, Sakane T, Yamamoto A, Minamino N, Miyazato M, Kangawa K, Hayashi Y.

J Med Chem. 2017 Sep 14;60(17):7613. doi: 10.1021/acs.jmedchem.7b01148. Epub 2017 Aug 18. No abstract available.

PMID:
28820261
47.

Social isolation suppresses actin dynamics and synaptic plasticity through ADF/cofilin inactivation in the developing rat barrel cortex.

Tada H, Miyazaki T, Takemoto K, Jitsuki S, Nakajima W, Koide M, Yamamoto N, Taguchi A, Kawai H, Komiya K, Suyama K, Abe H, Sano A, Takahashi T.

Sci Rep. 2017 Aug 16;7(1):8471. doi: 10.1038/s41598-017-08849-3.

48.

Development of Potent Myostatin Inhibitory Peptides through Hydrophobic Residue-Directed Structural Modification.

Takayama K, Rentier C, Asari T, Nakamura A, Saga Y, Shimada T, Nirasawa K, Sasaki E, Muguruma K, Taguchi A, Taniguchi A, Negishi Y, Hayashi Y.

ACS Med Chem Lett. 2017 Jun 6;8(7):751-756. doi: 10.1021/acsmedchemlett.7b00168. eCollection 2017 Jul 13.

49.

Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women.

Nakamura Y, Suzuki T, Kamimura M, Ikegami S, Murakami K, Uchiyama S, Taguchi A, Kato H.

Bone Res. 2017 Jun 13;5:16055. doi: 10.1038/boneres.2016.55. eCollection 2017.

50.

PAX2 is dispensable for in vitro nephron formation from human induced pluripotent stem cells.

Kaku Y, Taguchi A, Tanigawa S, Haque F, Sakuma T, Yamamoto T, Nishinakamura R.

Sci Rep. 2017 Jul 3;7(1):4554. doi: 10.1038/s41598-017-04813-3.

Supplemental Content

Loading ...
Support Center